13G/A filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP and 3 other reporting persons reported 3,772,885 MBX shares, 7.8% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:10:17 UTC.
- Accession
- 0001104659-26-128295
- Filer
- CIK 1855655
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Subject
- MBX · MBX Biosciences, Inc.
- Shares
- 3,772,885
- Percent of class
- 7.8%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group Paradigm Biocapital Advisors LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | PN | 3,772,885 | 0 | 3,772,885 | 0 | 3,772,885 | 7.8% |
| Paradigm BioCapital Advisors GP LLC | OO | 3,772,885 | 0 | 3,772,885 | 0 | 3,772,885 | 7.8% |
| Senai Asefaw, M.D. | IN | 3,772,885 | 0 | 3,772,885 | 0 | 3,772,885 | 7.8% |
| Paradigm BioCapital International Fund Ltd. | CO | 3,324,531 | 0 | 3,324,531 | 0 | 3,324,531 | 6.9% |